Ken Griffin Singular Genomics Systems, Inc. Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.4 - $0.61 $28,339 - $43,217	70,848 Added 153.78%	116,920 $59,000
Q4 2023 Feb 14, 2024	SELL	$0.33 - $0.58 $5,857 - $10,295	-17,750 Reduced 27.81%	46,072 $21,000
Q3 2023 Nov 14, 2023	BUY	$0.37 - $0.99 $13,120 - $35,105	35,460 Added 125.03%	63,822 $24,000
Q2 2023 Aug 14, 2023	BUY	$0.78 - $1.28 $17,046 - $27,973	21,854 Added 335.8%	28,362 $23,000
Q1 2023 May 15, 2023	BUY	$1.1 - $2.95 $1,791 - $4,805	1,629 Added 33.39%	6,508 $7,000
Q4 2022 Feb 14, 2023	SELL	$1.82 - $2.71 $97,180 - $144,703	-53,396 Reduced 91.63%	4,879 $9,000
Q3 2022 Nov 14, 2022	BUY	$2.5 - $4.73 $59,292 - $112,181	23,717 Added 68.63%	58,275 $145,000

1.43M

Ticker OMIC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 71,193,296
Market Cap $881M
Description
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.